120 related articles for article (PubMed ID: 21693749)
1. Can treatment of chronic inflammatory diseases reduce the risk of diabetes mellitus?
Bongartz T; Kudva Y
JAMA; 2011 Jun; 305(24):2573-4. PubMed ID: 21693749
[No Abstract] [Full Text] [Related]
2. Association between disease-modifying antirheumatic drugs and diabetes risk in patients with rheumatoid arthritis and psoriasis.
Solomon DH; Massarotti E; Garg R; Liu J; Canning C; Schneeweiss S
JAMA; 2011 Jun; 305(24):2525-31. PubMed ID: 21693740
[TBL] [Abstract][Full Text] [Related]
3. Hydroxychloroquine use and decreased risk of diabetes in rheumatoid arthritis patients.
Bili A; Sartorius JA; Kirchner HL; Morris SJ; Ledwich LJ; Antohe JL; Dancea S; Newman ED; Wasko MC
J Clin Rheumatol; 2011 Apr; 17(3):115-20. PubMed ID: 21441823
[TBL] [Abstract][Full Text] [Related]
4. [Cardiovascular risk in systemic inflammatory diseases].
Marsico F; Parente A; Paolillo S; Casaretti L; Lo Iudice F; Pirozzi E; Conte S; Iardino E; Gambardella F; Della Ratta GL; Cirillo A; Vitagliano A; Filardi PP
G Ital Cardiol (Rome); 2013; 14(7-8):517-25. PubMed ID: 23877549
[TBL] [Abstract][Full Text] [Related]
5. Risk of diabetes in patients with rheumatoid arthritis taking hydroxychloroquine.
Di Comite G; Rossi CM
JAMA; 2007 Nov; 298(20):2368-9; author reply 2369-70. PubMed ID: 18042914
[No Abstract] [Full Text] [Related]
6. Do Tumor Necrosis Factor (TNF) Inhibitors Improve the Glycemic Control in Patients with Rheumatoid Arthritis and Concomitant Diabetes Mellitus?
Danve AS; Kulkarni S
Am J Ther; 2017 May; 24(3):e347-e350. PubMed ID: 26103543
[TBL] [Abstract][Full Text] [Related]
7. Pharmacology of TNF blockade in rheumatoid arthritis and other chronic inflammatory diseases.
Taylor PC
Curr Opin Pharmacol; 2010 Jun; 10(3):308-15. PubMed ID: 20172761
[TBL] [Abstract][Full Text] [Related]
8. Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial.
van Vollenhoven RF; Ernestam S; Geborek P; Petersson IF; Cöster L; Waltbrand E; Zickert A; Theander J; Thörner A; Hellström H; Teleman A; Dackhammar C; Akre F; Forslind K; Ljung L; Oding R; Chatzidionysiou A; Wörnert M; Bratt J
Lancet; 2009 Aug; 374(9688):459-66. PubMed ID: 19665644
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of rheumatoid arthritis by inhibition of tumor necrosis factor with infliximab or etanercept].
Verhoeven AC; Boers M
Ned Tijdschr Geneeskd; 2001 Nov; 145(47):2294-5. PubMed ID: 11760611
[No Abstract] [Full Text] [Related]
10. Drugs for rheumatoid arthritis.
Med Lett Drugs Ther; 2000 Jul; 42(1082):57-64. PubMed ID: 10887424
[No Abstract] [Full Text] [Related]
11. Disease-modifying antirheumatic drugs.
Brasington R
J Hand Surg Am; 2009 Feb; 34(2):347-8. PubMed ID: 19181237
[No Abstract] [Full Text] [Related]
12. Canadian Consensus Conference on hydroxychloroquine.
Canadian rheumatology association
J Rheumatol; 2000 Dec; 27(12):2919-21. PubMed ID: 11128686
[No Abstract] [Full Text] [Related]
13. Hydroxychloroquine and risk of diabetes in patients with rheumatoid arthritis.
Wasko MC; Hubert HB; Lingala VB; Elliott JR; Luggen ME; Fries JF; Ward MM
JAMA; 2007 Jul; 298(2):187-93. PubMed ID: 17622600
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular risk in rheumatoid arthritis: how to lower the risk?
van Breukelen-van der Stoep DF; Klop B; van Zeben D; Hazes JM; Castro Cabezas M
Atherosclerosis; 2013 Nov; 231(1):163-72. PubMed ID: 24125429
[TBL] [Abstract][Full Text] [Related]
15. Disease-modifying anti-inflammatory bowel disease drugs (DMAIDs): the missing term in the literature.
Peyrin-Biroulet L
Am J Gastroenterol; 2013 May; 108(5):859-60. PubMed ID: 23644972
[No Abstract] [Full Text] [Related]
16. Diabetes mellitus risk in rheumatoid arthritis: reduced incidence with anti-tumor necrosis factor α therapy.
Antohe JL; Bili A; Sartorius JA; Kirchner HL; Morris SJ; Dancea S; Wasko MC
Arthritis Care Res (Hoboken); 2012 Feb; 64(2):215-21. PubMed ID: 21972198
[TBL] [Abstract][Full Text] [Related]
17. Hypoglycemia induced by hydroxychloroquine in a patient treated for rheumatoid arthritis.
Unübol M; Ayhan M; Guney E
J Clin Rheumatol; 2011 Jan; 17(1):46-7. PubMed ID: 21169846
[No Abstract] [Full Text] [Related]
18. The new era in the treatment of rheumatoid arthritis.
Putterman C
Am J Orthop (Belle Mead NJ); 2007 Jul; 36(7 Suppl):2-4. PubMed ID: 17694188
[No Abstract] [Full Text] [Related]
19. [Up-date on the use of infliximab in dermatology. Introduction].
Sánchez-Carazo J
Actas Dermosifiliogr; 2008 Jul; 99 Suppl 4():1. PubMed ID: 19080984
[No Abstract] [Full Text] [Related]
20. Developing a new generation of TNFalpha antagonists for the treatment of rheumatoid arthritis.
Fleischmann R; Shealy D
Mol Interv; 2003 Sep; 3(6):310-8. PubMed ID: 14993463
[No Abstract] [Full Text] [Related]
[Next] [New Search]
